Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology
Movement Disorders Clinical Practice · 2024
DOI: 10.1002/mdc3.14068 ↗Kurz gefasst
Fallbericht in der Zeitschrift Movement Disorders Clinical Practice, 2024. Verfasst von Lauren M Jackson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Parkinson Disease, Lewy Bodies, Mutation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Michael J. Fox Foundation for Parkinson's Research, Arizona Biomedical Research Commission, Mayo Clinic Foundation.
Abstract (Originalsprache)
Background
The G2019S leucine‐rich repeat kinase 2 (LRRK2) gene mutation is an important and commonly found genetic determinant of Parkinson's disease (PD). The neuropathological findings associated with this mutation have thus far been varied but are most often associated with Lewy body (LB) pathology.
Objective
Describe a case of clinical Parkinson's disease with levodopa responsiveness found to have LRRK2 mutations and the absence of Lewy bodies.
Method
We present an 89‐year‐old man with a 10‐year history of slowly progressive parkinsonism suspected to be secondary to Parkinson's disease.
Results
Neuropathological evaluation revealed nigral degeneration without Lewy bodies or Lewy neurites, but there were frequent tau‐immunopositive neurites and astrocytes in the putamen and substantia nigra, neocortical glial tau positive astrocytes associated with aging‐related tau astrogliopathy (ARTAG), as well as neurofibrillary tangles, beta amyloid plaques, and amyloid angiopathy typical of advanced Alzheimer's disease. G2019S LRRK2 homozygous mutations were found.
Conclusion
This case illustrates that levodopa‐responsive clinical PD caused by G2019S LRRK2 mutations can occur without Lewy bodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.
- Department of Neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA.
- Barrow Neurological Institute, Phoenix, Arizona, USA.
ORCID-Profile: Lauren M Jackson, Cecilia Tremblay, Thomas G Beach, Charles H Adler
Förderung
- Michael J. Fox Foundation for Parkinson's Research
- Arizona Biomedical Research Commission
- Mayo Clinic Foundation
- NIA NIH HHS
- Arizona Department of Health Services
- National Insitute on Aging
- NINDS NIH HHS
- Banner Health Foundation
Zitieren
APA
Jackson, L. M., Woodruff, B. K., Tremblay, C., Shill, H. A., Beach, T. G., Serrano, G. E., & Adler, C. H. (2024). Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14068
Vancouver
Jackson LM, Woodruff BK, Tremblay C, Shill HA, Beach TG, Serrano GE, et al. Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology. Movement Disorders Clinical Practice. 2024. doi:10.1002/mdc3.14068
BibTeX
@article{Jackson2024,
author = {Jackson, Lauren M and Woodruff, Bryan K and Tremblay, Cecilia and Shill, Holly A and Beach, Thomas G and Serrano, Geidy E and Adler, Charles H},
title = {Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology},
journal = {Movement Disorders Clinical Practice},
year = {2024},
doi = {10.1002/mdc3.14068}
}
EUVIMED